We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MULTIPLE GENERIC FIRMS LAUNCH VERSIONS OF GSK's WELLBUTRIN SR
MULTIPLE GENERIC FIRMS LAUNCH VERSIONS OF GSK's WELLBUTRIN SR
March 23, 2004
Generic firm Andrx has relinquished its 180-day exclusivity rights to the 150-mg strength version of GlaxoSmithKline’s antidepressant Wellbutrin SR (bupropion HCl extended-release) — a move that clears the way for final FDA approval of multiple generic competitors.